Elanco Animal Health Inc reports results for the quarter ended June 30 - Earnings Summary

• Elanco Animal Health Inc ELAN.N reported quarterly adjusted earnings of 26 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 30 cents. The mean expectation of eleven analysts for the quarter was for earnings of 20 cents per share. Wall Street expected results to range from 17 cents to 21 cents per share.

• Revenue rose 4.8% to $1.24 billion from a year ago; analysts expected $1.19 billion.

• Elanco Animal Health Inc's reported EPS for the quarter was 2 cents​.

• The company reported quarterly net income of $11 million.

• Elanco Animal Health Inc shares had fallen by 2.3% this quarter and gained 15.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 12.8% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

• Wall Street's median 12-month price target for Elanco Animal Health Inc is $17.00, about 17.9% above its last closing price of $13.95

This summary was machine generated from LSEG data August 7 at 04:25 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)